"Liver" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.
| Descriptor ID |
D008099
|
| MeSH Number(s) |
A03.620
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Liver".
Below are MeSH descriptors whose meaning is more specific than "Liver".
This graph shows the total number of publications written about "Liver" by people in this website by year, and whether "Liver" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 7 | 5 | 12 |
| 1994 | 1 | 2 | 3 |
| 1995 | 3 | 1 | 4 |
| 1996 | 4 | 3 | 7 |
| 1997 | 6 | 2 | 8 |
| 1998 | 4 | 6 | 10 |
| 1999 | 1 | 5 | 6 |
| 2000 | 6 | 3 | 9 |
| 2001 | 2 | 2 | 4 |
| 2002 | 2 | 1 | 3 |
| 2003 | 5 | 4 | 9 |
| 2004 | 1 | 6 | 7 |
| 2005 | 6 | 6 | 12 |
| 2006 | 6 | 2 | 8 |
| 2007 | 1 | 8 | 9 |
| 2008 | 2 | 2 | 4 |
| 2009 | 4 | 6 | 10 |
| 2010 | 4 | 11 | 15 |
| 2011 | 4 | 7 | 11 |
| 2012 | 5 | 7 | 12 |
| 2013 | 5 | 4 | 9 |
| 2014 | 5 | 4 | 9 |
| 2015 | 6 | 1 | 7 |
| 2016 | 4 | 9 | 13 |
| 2017 | 8 | 7 | 15 |
| 2018 | 7 | 5 | 12 |
| 2019 | 5 | 8 | 13 |
| 2020 | 2 | 7 | 9 |
| 2021 | 7 | 9 | 16 |
| 2022 | 1 | 8 | 9 |
| 2023 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver" by people in Profiles.
-
Using IV-Tubing "Bridge" from Splenic Artery to Superior Mesentery Artery to Create a Single Arterial Cannulation for Normothermic Machine Perfusion When Donor Liver Has Replaced Right Hepatic Artery. Am J Case Rep. 2023 Jul 16; 24:e940437.
-
Postprandial triglycerides and fibroblast growth factor 19 as potential screening tools for paediatric non-alcoholic fatty liver disease. Pediatr Obes. 2023 04; 18(4):e13007.
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice. J Lipid Res. 2023 03; 64(3):100340.
-
Early infiltrating macrophage subtype correlates with late-stage phenotypic outcome in a mouse model of hepatorenal fibrocystic disease. Lab Invest. 2021 10; 101(10):1382-1393.
-
17a-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. Am J Physiol Endocrinol Metab. 2023 02 01; 324(2):E120-E134.
-
TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis. Nat Commun. 2022 09 28; 13(1):5696.
-
Development of a Risk Score to Predict Post-Discharge Rehabilitation Care After Liver Metastasectomy. J Surg Res. 2022 Dec; 280:44-49.
-
Cinnabarinic Acid Provides Hepatoprotection Against Nonalcoholic Fatty Liver Disease. J Pharmacol Exp Ther. 2022 10; 383(1):32-43.
-
Multi-center living liver donor quality of life survey up to 20 years after donor hepatectomy and association with surgical outcomes. HPB (Oxford). 2022 Nov; 24(11):1975-1979.
-
Megakaryocyte/platelet-derived TGF-ß1 inhibits megakaryopoiesis in bone marrow by regulating thrombopoietin production in liver. Blood Adv. 2022 06 14; 6(11):3321-3328.